UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000041095 |
|---|---|
| Receipt number | R000046933 |
| Scientific Title | Examination of the recurrence rate in the treatment of urolithiasis in patients taking beta-adrenergic receptor agonists |
| Date of disclosure of the study information | 2020/07/13 |
| Last modified on | 2020/07/14 19:11:20 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Examination of the recurrence rate in the treatment of urolithiasis in patients taking beta-adrenergic receptor agonists
Acronym
Examination of the recurrence rate in the treatment of urolithiasis in patients taking beta-adrenergic receptor agonists
Scientific Title
Examination of the recurrence rate in the treatment of urolithiasis in patients taking beta-adrenergic receptor agonists
Scientific Title:Acronym
Relationship between beta-adrenergic receptor agonists and ureteral stones
Region
| Japan |
Condition
Condition
Ureteral stones
Classification by specialty
| Surgery in general | Urology | Emergency medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the clinical effects of beta-adrenergic receptor agonists on the treatment of ureteral stones
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Complete fracture rate of ureteral stones, postoperative recurrence rate, HU value
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 10 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
All patients treated with ureteral stones at Showa University Fujigaoka Hospital
Key exclusion criteria
(1) Patients under 10 years old
(2) Patients who do not get written consent
(3) Patients who cannot be examined by CT
(4) Patients scheduled to be treated in another hospital
(5) Patients who are judged to be inappropriate by other researchers
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Yuki |
| Middle name | |
| Last name | Matusi |
Organization
Showa University Fujigaoka Hospital
Division name
Urology Department
Zip code
227-8501
Address
1-30 Fujigaoka Aoba-ku Yokohama Kanagawa Japan
TEL
045-971-1151
hyperzector555@med.showa-u.ac.jp
Public contact
Name of contact person
| 1st name | Yuki |
| Middle name | |
| Last name | Matsui |
Organization
Showa University Fujigaoka Hospital
Division name
Urology Department
Zip code
227-8501
Address
1-30 Fujigaoka Aoba-ku Yokohama Kanagawa Japan
TEL
045-971-1151
Homepage URL
hyperzector555@med.showa-u.ac.jp
Sponsor or person
Institute
Showa University Fujigaoka Hospital
Institute
Department
Personal name
Funding Source
Organization
Showa University Fujigaoka Hospital
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Showa University Fujigaoka Hospital Clinical Study Review Board
Address
1-30 Fujigaoka Aoba-ku Yokohama Kanagawa Japan
Tel
045-971-1151
hyperzector555@med.showa-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 07 | Month | 13 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2019 | Year | 12 | Month | 01 | Day |
Date of IRB
| 2019 | Year | 12 | Month | 18 | Day |
Anticipated trial start date
| 2019 | Year | 12 | Month | 19 | Day |
Last follow-up date
| 2026 | Year | 04 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Regarding the treatment of ureteral stones at Showa University Fujigaoka Hospital, we will investigate the effect of beta-adrenergic receptor stimulants and perform statistical analysis.
Management information
Registered date
| 2020 | Year | 07 | Month | 13 | Day |
Last modified on
| 2020 | Year | 07 | Month | 14 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046933
